Biotechnology company developing end-to-end AI foundation models that learn from diverse biological data to design sequence-based medicines, including mRNA, siRNA, antisense oligonucleotides, and peptides
Biotechnology company developing end-to-end AI foundation models that learn from diverse biological data to design sequence-based medicines, including mRNA, siRNA, antisense oligonucleotides, and peptides. It combines computational molecule design with in-house wet-lab validation and partners with drugmakers to customize models and co-design therapeutics.